Cargando…
Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience
Background: Thrombotic thrombocytopenic purpura (TTP) is associated with microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombosis. No comprehensive report exists on clinical characteristics and risk factors of relapse and mortality in Iranian TTP patients. In this study, we...
Autores principales: | Tavakoli Shiraji, Sahar, Rostami, Mohammad Reza, Kamranzadeh Foumani, Hosein, Mousavi, Seied Asadollah, Vaezi, Mohammad, Rad, Soroush, Babakhani, Davood, Barkhordar, Maryam, Bahri, Tanaz, Janbabaei, Ghasem, Malekmohammadi, Ashraf, Mohammadi, Saeed, Mansouri, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560647/ https://www.ncbi.nlm.nih.gov/pubmed/37817970 http://dx.doi.org/10.18502/ijhoscr.v17i3.13305 |
Ejemplares similares
-
Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the COVID-19 Pandemic: An Iranian Consensus
por: Mousavi, Seied Asadollah, et al.
Publicado: (2020) -
Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation
por: Barkhordar, Maryam, et al.
Publicado: (2021) -
Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia
por: Barkhordar, Maryam, et al.
Publicado: (2022) -
Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran
por: Mousavi, Seied Asadollah, et al.
Publicado: (2019) -
Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era
Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With
Long-term Follow-up
por: Tavakoli, Sahar, et al.
Publicado: (2023)